|
Published by: Kalorama Information
Published: May. 1, 1996 - 175 Pages Now 75% off the original sale price of $3,250.
Table of Contents
Chapter One: Executive Summary
Size of the Market
- Chemotherapeutic Agents
- Chemotherapeutic Adjuvants
- Biologic Agents
- Emerging Cancer Technologies
Introduction to Cancer Diseases
- Overview
- Description of Cancer
- Tumor Development
- Historical Background
- Cancer Prevalence, Incidence, and Frequency
- Current Treatment Options
- Antisense Nucleic Acids
- Bone Marrow Transplantation
- Chemotherapy
- Gene Therapy
- Hyperthermia
- Radiotherapy
- Surgery
- Targeted Drug Delivery
Industry Participants
- Pharmaceutical Companies
- Biotechnology Companies
The Products
- Chemotherapeutic Agents
- Alkylating/Alkaloid Agents
- Antibiotics
- Antimetabolites
- Hormones and Hormone Analogs
- Miscellaneous Antineoplastic Drugs
- Chemotherapeutic Adjuvants
- Biologic Agents
- Emerging Cancer Technologies
- Scope and Methodology
Introduction to Cancer
Overview
Description of Cancer
- Tumor Development
- Causes of Mutation
- Historical Background
Cancer Prevalence, Incidence, and Frequency
- Morbidity and Mortality
- Geographic Incidence
Bladder Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Breast Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Colon and Rectal Cancers
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Hodgkin’s Disease
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Kidney Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Leukemia
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Lung Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Non-Hodgkin’s Lymphoma
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Oral Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Ovarian Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Pancreatic Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Prostate Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Skin Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Stomach Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Uterine Cancer
- Incidence, Prevalence, and Mortality
- Causative Factors
- Treatment
Current Treatment Options
- Antisense Nucleic Acids
- Bone Marrow Transplantation
- Chemotherapy
- Advantages
- Disadvantages
- Gene Therapy
- Hyperthermia
- Radiotherapy
- Advantages
- Disadvantages
- Research and Development
- Surgery
- Advantages
- Disadvantages
- Use with Other Therapies
- Targeted Drug Delivery
Chapter Three: The Products
Product Categories
Industry Participants
- Pharmaceutical Companies
- Biotechnology Companies
Chemotherapeutic Agents
Alkylating/Alkaloid Agents
- BiCNU
- CeeNU
- Cytoxan
- Hexalen
- IFEX
- Leukeran
- Matulane
- Myleran
- Neosar
- Oncovin
- Paraplatin
- Platinol
- Velban
- Zanosar
Antibiotics
- Adriamycin
- Blenoxane
- Cerubidine
- Cosmegen
- Doxorubicin
- Idamycin
- Mutamycin
Antimetabolites
- Cytosar-U
- Efudex
- Fludara
- Fluorouracil
- FUDR
- Hydrea
- Methotrexate
- Mithracin
- Nipent
- Purinethol
- Tabloid
Hormones and Hormone Analogs
- Arimidex
- Casodex
- Depo-Provera
- Estrace
- Eulexin
- Lupron
- Megace
- Nolvadex
- Sandostatin
- Stilphostrol
- TACE
- Teslac
- Zoladex
Miscellaneous Antineoplastic Drugs
- BCG
- Celestone Soluspan
- Elspar
- Emcyt
- Leustatin
- Lysodren
- Proleukin
- Taxol
- VePesid
- Vesanoid
Combinational Therapies
- Daunorubicin-Vincristine-Prednisone
- Levamisole-Fluorouracil
- Methotrexate Combinations
Chemotherapeutic Adjuvants
- Antiemetic Agents
- Hypercalcemia Agents
- Myelosuppressive Agents
Biologic Agents
- Interferons
- Alpha Interferon
- Beta Interferon
- Gamma Interferon
- Products
- Intron A
- Roferon-A
- Interleukins
- Proleukin
- Other
- Monoclonal Antibodies
- Products
- Radioisotope and Toxin Immunoconjugates
- Oncolysin
- Other
- Nonadjuvant Growth Factors
- Colony-Stimulating Factors
- Tumor Necrosis Factor
Emerging Cancer Technologies
- Antisense Nucleic Acids
- Chemoprotectants and Radioprotectants
- Gene Therapy
- Oncogenes and Tumor Suppressor Genes
- Photodynamic Therapy Compounds
- Vaccines
- Different Approaches
- Outlook
Products Nearing the Market
- DaunoXome
- Etopophos
- Fareston
- Gemzar
- Nilandron
- Taxotere
Chapter Four: Issues and Trends
Overview of the Pharmaceutical Industry
Managed Care
- Driving Down Hospital Costs
- Geographic Concentration of Managed Care Hospitals
- Impact of Managed Care on Cancer Care
- Insurance reimbursement
- The Cancer Center: A New Managed Care Subsidiary
- Salick Health Care
- Alta Bates Medical Center
- National Comprehensive Cancer Network
- The National Cancer Institute
- Research Grants
- Cancers Receive the Most Funding
- Private Funding for Research
- Changing Investment Attitudes
- Collaborative Agreements
- Product Label Expansion and Patent Coverage Extension
Chapter Five: The U.S. Market
Methodology
Size of the Market
- Sales and Forecast
- Market Trends
Chemotherapeutic Agents
- Sales and Forecast
- Market Share
- Bristol-Myers Squibb
- Zeneca
- Schering-Plough
- TAP Pharmaceuticals
Chemotherapeutic Adjuvants
- Sales and Forecast
- Market Share
- Antiemetic Agents
- Hypercalcemia Agents
- Myelosuppressive Agents
Biologic Agents
- Sales and Forecast
- Market Share
Emerging Cancer Technologies
- Sales and Forecast
- Market Share
Chapter Six: Competitor Profiles
Abbott Laboratories
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Research and Development
- Corporate Strategies
Agouron Pharmaceuticals, Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Research and Development
- AG-331 and AG-337
- AG-394
- Other
American Home Products Corporation
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Research and Development
Amgen Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Research and Development
- Neupogen
- Neu Differentiation Factor
- Stem Cell Factor
- Sales and Marketing
- Corporate Strategies
Bristol-Myers Squibb Company
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Research and Development
Centocor, Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Research and Development
- Sales and Marketing
Chiron, Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Research and Development
- Sales and Marketing
- Corporate Strategies
Ciba-Geigy Corporation
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Research and Development
- Sales and Marketing
- Corporate Strategies
Connaught Laboratories, Inc.
- History and Lines of Business
- Corporate Analysis
- Cancer Therapeutics
- Sales and Marketing
- Corporate Strategies
Genentech, Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Research and Development
- Sales and Marketing
- Corporate Strategies
Hoffmann-La Roche Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Research and Development
- Sales and Marketing
ImClone Systems, Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Research and Development
- Interventional Therapeutics
- Cancer Vaccines
- Blood Cell Growth Factors
- Corporate Strategies
Johnson & Johnson
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Ergamisol
- Procrit
- Research and Development
- Sales and Marketing
Eli Lilly And Company, Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Targeted Disease Categories
- Global Presence
- Critical Capabilities
- Cancer Therapeutic Products
- Oncovin
- Velban
- Research and Development
Pharmacia & Upjohn, Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Cytosar-U
- Zanosar
- Research and Development
Schering-Plough Corporation
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Eulexin
- Intron A
- Research and Development
- IL-4 and IL-10
- IL-11 and M-CSF
- Leucomax
- Temozolomide
- Other
- Sales and Marketing
Zeneca Inc.
- History and Lines of Business
- Financial Information
- Corporate Analysis
- Cancer Therapeutics
- Research and Development
- Sales and Marketing
Cancer Therapeutics
Company Names and Addresses
AbstractThis Kalorama Information report details the scientific and market trends of the $4-billion cancer therapeutics market. Learn about the impact of chemotherapeutics, biologic agents, cancer vaccines, genetic therapies, and other emerging technologies. Find out about strategies companies are using to extend the life span of brand-name cancer therapeutic products that are coming off patent. Leading players are profiled.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
|
About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.
© MarketResearch.com 2008
|
